The family lifestyles, actions and risk education (FLARE) study: Protocol for a randomized controlled trial of a sun protection intervention for children of melanoma survivors Journal Article


Authors: Wu, Y. P.; Stump, T. K.; Hay, J. L.; Aspinwall, L. G.; Boucher, K. M.; Deboeck, P. R.; Grossman, D.; Mooney, K.; Leachman, S. A.; Smith, K. R.; Wankier, A. P.; Brady, H. L.; Hancock, S. E.; Parsons, B. G.; Tercyak, K. P.
Article Title: The family lifestyles, actions and risk education (FLARE) study: Protocol for a randomized controlled trial of a sun protection intervention for children of melanoma survivors
Abstract: Background: Children of parents who had melanoma are more likely to develop skin cancer themselves owing to shared familial risks. The prevention of sunburns and promotion of sun-protective behaviors are essential to control cancer among these children. The Family Lifestyles, Actions and Risk Education (FLARE) intervention will be delivered as part of a randomized controlled trial to support parent-child collaboration to improve sun safety outcomes among children of melanoma survivors. Methods: FLARE is a two-arm randomized controlled trial design that will recruit dyads comprised of a parent who is a melanoma survivor and their child (aged 8–17 years). Dyads will be randomized to receive FLARE or standard skin cancer prevention education, which both entail 3 telehealth sessions with an interventionist. FLARE is guided by Social-Cognitive and Protection Motivation theories to target child sun protection behaviors through parent and child perceived risk for melanoma, problem-solving skills, and development of a family skin protection action plan to promote positive modeling of sun protection behaviors. At multiple assessments through one-year post-baseline, parents and children complete surveys to assess frequency of reported child sunburns, child sun protection behaviors and melanin-induced surface skin color change, and potential mediators of intervention effects (e.g., parent-child modeling). Conclusion: The FLARE trial addresses the need for melanoma preventive interventions for children with familial risk for the disease. If efficacious, FLARE could help to mitigate familial risk for melanoma among these children by teaching practices which, if enacted, decrease sunburn occurrence and improve children's use of well-established sun protection strategies. © 2023 Elsevier Inc.
Keywords: adolescent; adult; child; cancer risk; outcome assessment; genetic predisposition to disease; protein p16; sunscreen; cancer prevention; melanoma; melanin; sun exposure; skin neoplasms; health behavior; patient education; psychology; randomized controlled trials as topic; cancer survivor; skin tumor; skin surface; pilot study; problem solving; cyclin dependent kinase inhibitor 2a; children; genetic predisposition; sunscreening agents; skill; family; health education; lifestyle; life style; sunburn; intervention; prevention; cancer survivors; randomized controlled trial (topic); skin protection; skin color; childhood cancer survivor; telehealth; reflectometry; parental attitude; humans; human; male; female; article
Journal Title: Contemporary Clinical Trials
Volume: 131
ISSN: 1551-7144
Publisher: Elsevier Inc.  
Date Published: 2023-08-01
Start Page: 107276
Language: English
DOI: 10.1016/j.cct.2023.107276
PUBMED: 37393004
PROVIDER: scopus
PMCID: PMC10529923
DOI/URL:
Notes: The MSK Cancer Center Support Grant (P30 CA008748) is acknowledged in the PDF -- Corresponding author is MSK author: Jennifer L. Hay -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Jennifer L Hay
    264 Hay